FDA Market Authorization for BONESUPPORT’s CERAMENT G

BONESUPPORT Cerament G Bone Graft Substitute

BONESUPPORT received market authorization from FDA for the company's antibiotic eluting product CERAMENT G, for the indication bone infection (osteomyelitis).

CERAMENT G previously received Breakthrough Device Designation in 2021. As what is reportedly the first injectable combination antibiotic bone graft substitute, CERAMENT G can be...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us